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20 The Journal of Thoracic and Cardiobjective: Several techniques have been reported for the localization of small
ulmonary nodules in thoracoscopic resection. In the present study we examined the
sefulness and complications of computed tomography-guided lipiodol marking for
horacoscopic resection in our experience of 174 nodules.
ethods: Computed tomography-guided lipiodol marking was performed on 174
odules less than 30 mm in size. Of these nodules, 45 showed ground-glass opacity
mages and 129 showed solid images on computed tomography. The mean size of
he nodules was 10  6 mm (range, 2-30 mm), and their mean depth from the
leural surface was 10  7 mm (range, 0-30 mm). One to 7 days before thoracos-
opy, all of the nodules were marked with 0.4 to 0.5 mL of lipiodol by using
omputed tomography. The marked nodules were grasped with a ring-shaped
orceps during fluoroscopy and resected by means of thoracoscopy.
esults: All the nodules could be marked and localized by means of fluoroscopy as
clear spot during thoracoscopic surgery. Complications of the marking were chest
ain requiring analgesia in 16 (11%) patients, hemosputum in 11 (6%) patients,
neumothorax in 30 (17%) patients, and hemopneumothorax in 1 (0.6%) patient.
leven (6%) patients with pneumothorax required drainage, and the patient with
emopneumothorax required an emergency operation. No other complications were
bserved.
onclusion: Lipiodol marking is a useful, safe, and inexpensive procedure for local-
zing ground-glass opacity lesions, small pulmonary nodules, or both for thoracoscopic
esection.
ecently, small pulmonary nodules have been frequently detected with high-
resolution computed tomography (CT).1,2 Performing a percutaneous o
transbronchial biopsy for small pulmonary nodules is often difficult, and
ence thoracoscopic surgical techniques have been used in diagnostic excisional
iopsies, as well as in therapeutic resection. However, a major factor that limits the
uccess of thoracoscopic resection in the case of small or deeply situated pulmonary
odules is the difficulty in localizing the target nodule because of the lack of digital
alpation. Furthermore, a bronchioloalveolar carcinoma with a ground-glass opacity
GGO) finding on CT cannot be palpated or visualized frequently, even in the case
f lesions that are located just beneath the visceral pleura. Therefore several
echniques have been reported for localization of such small nodules or GGO
esions.3-18 However, these techniques can result in complications, such as pothorax, hemorrhage, and air embolism. Since 1999, we have used CT-guided
vascular Surgery ● August 2006
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G
TSipiodol marking for the thoracoscopic resection of s
esions. The purpose of our study is to examine the u
ess and safety of this procedure.
aterials and Methods
ligibility
he CT-guided lipiodol marking was approved by the e
ommittee of Saiseikai Central Hospital in January 1999. Wr
nformed consent was obtained from all patients after they
ussed the risks and benefits of the procedure with the surg
he nodules that were thought to be difficult to localize d
horacoscopy, such as GGO lesions, nodules situated at a co
rable depth from the pleural surface, and nodules smaller than
 cm, were candidates for this procedure. The following nodules
xcluded: (1) nodules larger than 30 mm in size; (2) nodules l
ithin the inner two third of the lung; and (3) solid nodules th
arger than 10 mm in size and located within 10 mm from the
urface.
atients
etween January 1999 and June 2005, CT-guided lipiodol mar
as performed on 174 pulmonary nodules in 150 patients. 
ean age of the patients was 62  11 years (range, 35-84 years
able 1 shows the characteristics of the nodules. The mean size 
he nodules was 10  6 mm (range, 2-30 mm). The i r mean distance
rom the pleural surface was 10  7 mm (range, 0-30 mm). The
ere 45 GGO lesions and 129 solid lesions. All the nodules
etected with chest CT; however, they could not be det
learly with chest roentgenograms.
arking Technique
he procedure used for marking was as follows. After 0.5 
tropine and 15 mg of pentazocine was injected, the patients 
laced on the CT table in a suitable position (supine or pro
caled paper with metal wires was placed firmly on the patien
he CT scan was performed. The shortest distance from the n
o the thoracic wall was selected as the injection site (FigureA).
he site for marker injection was marked on the skin, and the
nd depth of the needle required to reach the nodule were deter
fter local anesthesia was administered to the thoracic wall, a 
3-gauge needle was introduced from the point marked on the s
he nodule, in keeping with the angle and depth measured.
yringe was withdrawn to confirm that no blood had flowed 
ard, and 0.4 to 0.5 mL of lipiodol (Lipiodol Ultrafluid; Labor
uerbet, Aulnay-Sous-Bois, France), which is generally used 
ontrast medium for lymphatic vessels, was then injected in a 
hot. The presence of the injected materials was confirmed by m
f CT after the marking (Figure 1, B). Thoracoscopic surgery wa
Abbreviations and Acronyms
CT  computed tomography
GGO  ground-glass opacity
TTNA transthoracic needle aspirationerformed 1 to 7 days (mean, 1.7  1.1 days) after marking. t
The Journal of Thoracicl-
.
e
d
ere
ral
e
f
e
A
d
e
le
.
r
o
e
-
e
e
s
horacoscopic Resection Technique
horacoscopy was performed during one-lung anesthesia by u
 double-lumen tube. A C-arm–shaped fluoroscopic unit was 
o detect the radiopaque nodules, and the radiopaque nodule
rasped with a ring-shaped forceps during fluoroscopy in mul
rojections (Figure 1, C). The forceps was then moved in sev
irections to confirm that the nodule was grasped within a r
he forceps. The grasped nodule was resected with an endostapler.
he resected specimens were removed with a surgical bag. Suc-
essive resection of the nodules was confirmed by viewing the
adiopaque nodule within the resected specimen during fluoros-
opy. The nodules were histologically diagnosed by means of
outine intraoperative pathologic examination, with the exception
f the GGO lesions that were less than 10 mm in size; these were
istologically diagnosed by a permanent section.
esults
ll the nodules could be marked with lipiodol on the CT
mages. Even when the lipiodol could not mark within the
odules, it marked within 10 mm from the nodules, which
aused no difficulty in their localization. All the nodules
ere successfully localized and resected during thoracos-
opy without conversion to open thoracotomy. Even a nod-
le that was marked 7 days before the thoracoscopy could
e detected during fluoroscopy as a clear spot. Of the 174
odules, 107 (61%) were diagnosed as malignant, and 67
39%) were diagnosed as benign (Table 2). For th
atients with primary lung cancers, 48 were followed with
horacoscopic lobectomy, and 10 were followed with tho-
acoscopic segmentectomy. The other 23 patients did not
ndergo the additional resection because of bronchioloal-
eolar cell carcinoma of the intraoperative frozen section,
oor risk of the patients, or both. All of the surgical margins
n patients treated with thoracoscopic wedge resection showed
o malignancy.
Table 3 shows the complications accompanying lipio
arking. Sixteen (11%) patients had chest pain that required
nalgesia. Eleven (6%) patients had a little hemosputum.
hirty (17%) patients had pneumothorax, and 11 (6%) of
ABLE 1. Characteristics of the nodules
ean size, mm (range) 10  6 (2-30)
ean distance from the pleura, mm (range) 10  7 (0-30)
ocation
Right upper lobe 42
Right middle lobe 21
Right lower lobe 37
Left upper lobe 34
Left lower lobe 40
T findings
Ground-glass opacity 45
Solid 129
T, Computed tomography.hese patients required drainage. One (0.6%) patient had
and Cardiovascular Surgery ● Volume 132, Number 2 321
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G
TSemopneumothorax caused by peeling off of the ple
dhesion, including blood vessels.
One patient had bilateral pulmonary nodules, both
hich were marked by lipiodol; the patient was giv
iagnosis of metastatic colon cancer by means of an 
ateral thoracoscopy. Therefore the marked contralate
odule was followed by CT, which had been marke
ipiodol for 3 months.
iscussion
everal methods have been reported for the localization of
mall pulmonary nodules. These include the hook-wire
echnique,3-7 endoscopic ultrasonography,8,9 barium mark-
ng through bronchoscopy,10,11 and percutaneous injection
f dyes,12,13 colored collagen,14 lipiodol,15,16 agar,17 and
arium.18 The original dye method, because of rapid di-
ion around the lung tissue after injection, has the following
rawbacks: (1) the marking must be performed within 3
ours before the thoracoscopy to enable dye detection, and
herefore both CT and the operating room must be used
imultaneously, and (2) the injection site appears blurred
ecause of the diffusion. With the agar marking procedure,
t is difficult to localize a deeply situated nodule because the
alpation of the marked nodules is requisite. The ultrasound
echnique requires complete collapse of the lung, which is
ften impossible in patients with emphysema, resulting in a
ailure rate of 40% in localizing the nodules.9 The hook-
ire technique has been recently reported to cause massive
ir embolism,19-23 which led to its prohibition in Jap
arium marking with a CT-guided bronchoscopy is com-
licated because it requires simultaneous use of bronchos-
opy and CT, and marking one nodule with this procedure
igure 1. A, Computed tomographic (CT) scan showing a nodule
ith ground-glass opacity (GGO) in the left lower lobe. *The
hortest distance from the nodule to the thoracic wall was
elected as the injection site. The several lines on the chest wall
eveal the metal wires of scaled-paper. (B) CT showing the tumor
arked with lipiodol. C, Intraoperative fluoroscopic imaging
howing the radiopaque nodule grasped within a ring-shaped
ABLE 2. Pathologic diagnosis of the nodules
Malignant (n  107)
Primary lung cancer 81
Metastatic lung cancer 26
Benign (n  67)
Tuberculosis 36
Old inflammation 11
Pulmonary lymphoid tissue 9
Atypical adenomatous hyperplasia 8
Hamartoma 3orceps. The nodule is indicated with an arrow.st 2006
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G
TSequires approximately 30 minutes (range, 15-60 m
tes).11 In addition, barium itself can be seen as a lesi
ematoxylin and eosin–stained sections and also can ca
n inflammatory change of the lung tissue, which m
ake a histologic diagnosis difficult.
We previously marked a nodule with lipiodol and
leural surface with colored collagen; this enabled a c
aratively easier localization of the nodules than when 
ipiodol was used.16 However, 1 mL of collagen co
pproximately $80.00. Therefore since March 2002, 
tarted using only lipiodol to mark pulmonary nodu
hus without using colored collagen, the nodules mar
ith lipiodol could be localized during fluoroscopy with
reat difficulty, resulting in a success rate of 100%
horacoscopic biopsy. The marking procedure with lipio
as the following advantages: (1) overresection of the 
al lung tissue around the nodules was prevented bec
ipiodol marked the nodules as clear spots that were
han 1 cm in size during fluoroscopy; (2) the lipiodo
ained for a long time, up to 3 months after the ma
hich solves the problem of requiring both CT and
perating room simultaneously; (3) although the bari
arking procedure affects pathologic findings caused by
nflammatory response and barium itself, lipiodol did 
ffect the pathologic findings; and (4) even in the ca
eeply situated nodules (ie, up to 30 mm from the p
urface in the present study), the lipiodol marking c
asily localize the nodules as a clear spot because it dif
nly to a small extent.
Transthoracic needle aspiration (TTNA) is also effect
n the diagnosis of pulmonary nodules.24-26 Although
TNA has been reported to have a false-negative rate o
o 11%,24 Layfield and colleagues25 reported that its diag-
ostic accuracy decreased to 60% for lesions smaller 
0 mm. Kashiwabara and associates26 reported that th
ositive diagnostic rate for nonmalignant lesions by u
TNA was only 56%. All the nodules in the present 
ere GGO lesions or small nodules deeply situated w
he lung, which were not only difficult to diagnose 
TNA but also difficult to locate by means of thoracos
nspection without marking. We therefore believe that G
able 3. Complications of lipiodol marking
No. of patients (%)
Chest pain requiring analgesia 16 (11)
Hemosputum 11 (6)
Pneumothorax 30 (17)
No treatment 19 (11)
Drainage 11 (6)
Hemopneumothorax 1 (0.6)esions or small nodules that are deeply situated should be
The Journal of Thoracicn
r
s
-
g,
f
l
d
y
iagnosed by means of thoracoscopic biopsy with preo
tive marking.
Although the complications of lipiodol marking inclu
emporary pain, a little hemosputum, pneumothorax, 
emopneumothorax, all of them arose because of the in
ion of the needle into the lung and not because o
ipiodol itself. Although we did not encounter air embo
uring the lipiodol marking, the frequency of massive
mbolism during percutaneous needle insertion into 
ung has been reported to be 0.02% to 0.07%.21 There have
een reports of 6 patients who experienced a massiv
mbolism during percutaneous marking procedures.19-23 In
 of the 6 patients, it was caused by the hook-wire tech
nd in 1 patient by the needle-marker procedure. The 
ive air embolisms could have occurred because of si
aneous injury of the bronchiole and the adjacent pulmo
ein.23 Because all 6 patients with massive air embol
ad nodules in the lower lobe, we believe that the 
issue of the lower lobe could be injured more easily b
ook wire or needle marker than that of upper lobe be
he former moves more with respiration during insertio
hese apparatuses than the latter. Therefore we usually i
ipiodol immediately after needle insertion without confi
ng the location of the needle tip by means of CT sca
nabling the time of placing the needle in the lung tis
e less than 10 seconds, which could decrease the 
amage caused by the needle.
Lipiodol itself poses a potential risk of embolism 
ause it is water insoluble. We therefore take the following
recautions: (1) before injection of lipiodol, the syringe is
ithdrawn to confirm that blood has not flowed backward,
nd (2) a minimum amount of lipiodol, up to 0.5 mL, is
njected.
Although the lipiodol marking procedure showed some
omplications caused by the needle insertion, they were not
f a serious nature. Because it is a simple, safe, and inex-
ensive method for localizing GGO lesions, small and
eeply situated pulmonary nodules, or both, we believe that
ipiodol marking is one of the gold standard procedures for
ocalization of these nodules during thoracoscopy.
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